Why are you looking at Gen-Probe Incorporated?
Capability
Service linesIN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING · TESTING LABORATORIES
Work mix: 100% prime · 0% sub · primary NAICS 561990 / PSC 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Where they win
Sole agencyRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
Agency buyer map
1 buyersRecompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Gen-Probe Incorporated’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $112.5M in play. Enter a work email for two figures the page cannot show.
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Gen-Probe Incorporated hold?
Gen-Probe Incorporated (UEI QNXWLAJDL4J3) shows $112.5M across 5120 award actions in SCOUT’s public USASpending-backed profile. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Gen-Probe Incorporated work with?
Gen-Probe Incorporated’s firm-wide obligated mix is led by Department of Defense (DOD) (1%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →